Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.abb.2011.04.001PMID 21501583PMCID PMC3095665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice

  2010cited by this paper
• PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division.

  2010cited by this paper
• Predicting Fibrosis Worsening in Obese Patients With NASH Through Parenchymal Fibronectin, HOMA-IR, and Hypertension

  2010cited by this paper
• Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide‐induced liver injury caused by ethanol in mice

  2009cited by this paper
• Implication of normal liver enzymes in liver disease

  2009cited by this paper
• Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease

  2009cited by this paper
• New Role of Resistin in Lipopolysaccharide-Induced Liver Damage in Mice

  2008cited by this paper
• Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets

  2008cited by this paper
• Mechanisms of hepatic fibrogenesis.

  2008cited by this paper
• Redox signaling in angiogenesis: role of NADPH oxidase.

  2006cited by this paper
• Critical Role of Plasminogen Activator Inhibitor-1 in Cholestatic Liver Injury and Fibrosis

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct–ligated rats

  2005cited by this paper
• Antifibrotic effects of a tissue inhibitor of metalloproteinase‐1 antibody on established liver fibrosis in rats

  2004cited by this paper
• Role of the renin‐angiotensin system in hepatic ischemia reperfusion injury in rats

  2004cited by this paper
• A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations

  2004cited by this paper
• “Hope” for the liver? Mechanistic insight into the role of the renin‐angiotensin system in hepatic fibrosis

  2004cited by this paper
• Liver fibrosis -- from bench to bedside.

  2003cited by this paper
• NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

  2003cited by this paper
• Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.

  2003cited by this paper
• Angiotensin II as a cardiovascular risk factor

  2002cited by this paper
• The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

  2002cited by this paper
• Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.

  2001cited by this paper
• Plasminogen activators direct reorganization of the liver lobule after acute injury.

  2001cited by this paper
• Angiotensin II and renal fibrosis.

  2001cited by this paper
• Blood-pressure reduction and cardiovascular risk in HOPE study.

  2001cited by this paper
• Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor.

  2000cited by this paper
• Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.

  2000cited by this paper
• Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity.

  2000cited by this paper
• AT 1-signalling in vascular smooth muscle

  2000cited by this paper
• Prothrombotic effects of angiotensin.

  2000cited by this paper
• Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.

  1999cited by this paper
• Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion*

  1999cited by this paper
• Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells.

  1998cited by this paper
• Cultured myofibroblasts generate angiotensin peptides de novo.

  1997cited by this paper
• Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction.

  1997cited by this paper
• The plasminogen‐activating system in hepatic stellate cells

  1996cited by this paper
• Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.

  1995cited by this paper
• The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor.

  1994cited by this paper
• Type I collagen gene regulation and the molecular pathogenesis of cirrhosis.

  1993cited by this paper
• Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.

  1990cited by this paper
• Plasminogen activator inhibitors--a review.

  1988cited by this paper
• Plasmin degradation of cartilage proteoglycan.

  1984cited by this paper
• Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

  1981cited by this paper

• Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction.

  2024cites this paper
• The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression

  2023cites this paper
• Hepatoprotective Effect of Cassia Auriculata in Ethanol Induced Albino Rats

  2020cites this paper
• Hepatic Stellate Cell e Speci fi c Platelet-Derived Growth Factor Receptor- a Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury

  2020cites this paper
• HEPATIC STELLATE CELL-SPECIFIC PLATELET-DERIVED GROWTH FACTOR RECEPTOR α LOSS REDUCES FIBROSIS AND PROMOTES REPAIR FOLLOWING HEPATOCELLULAR INJURY.

  2020cites this paper
• Serpine1 Knockdown Enhances MMP Activity after Flexor Tendon Injury in Mice: Implications for Adhesions Therapy

  2018cites this paper
• Alcoholic liver disease: Utility of animal models

  2018cites this paper
• Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease

  2017cites this paper
• Activation of cardiac renin–angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder

  2017cites this paper
• Pathogenesis of Alcoholic Liver Disease

  2016cites this paper
• Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis.

  2015cites this paper
• Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out Mice

  2015cites this paper
• Alpha‐1‐antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human

  2015cites this paper
• Cylindromatosis (CYLD) inhibits Streptococcus pneumonia-induced plasminogen activator inhibitor-1 expression via interacting with TRAF-6.

  2015cites this paper
• Kupffer cells in the liver.

  2013cites this paper
• Development of liver fibrosis during aging: effects of caloric restriction.

  2013cites this paper
• Mouse model of chronic and binge ethanol feeding (the NIAAA model)

  2013cites this paper
• Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.

  2013cites this paper
• The pathogenesis of oxaliplatin induced sinusoidal obstruction syndrome

  2013cites this paper
• A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma.

  2012cites this paper
• Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism

  2012cites this paper